Journal of the American Academy of Dermatology
Volume 62, Issue 3 , Pages 469-479 , March 2010

The dermal-based borderline melanocytic tumor: A categorical approach

  • Cynthia M. Magro, MD

      Affiliations

    • Weill Medical College of Cornell University, New York, New York
    • Corresponding Author InformationReprint requests: Cynthia M. Magro, MD, Department of Pathology, Weill Medical College of Cornell University, 1300 York Ave, F-309, New York, NY 10021.
    • ,
  • A. Neil Crowson, MD

      Affiliations

    • Regional Medical Laboratory, St. John's Medical Center, University of Oklahoma, Tulsa, Oklahoma
    • ,
  • Martin C. Mihm Jr., MD

      Affiliations

    • Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Kapil Gupta, MD

      Affiliations

    • Dermatology Group of the Carolinas, Concord, NC
    • ,
  • Michael J. Walker, MD

      Affiliations

    • The Ohio State University, Columbus, Ohio
    • ,
  • Garron Solomon, MD

      Affiliations

    • Strata Pathology Services Incorporated, Lexington, Massachusetts

References 

  1. Reed RJ, Ichinose H, Clark WH, Mihm MC. Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol. 1975;2:119–147
  2. Ward JR, Brady SP, Tada H, Levin NA. Pigmented epithelioid melanocytoma. Int J Dermatol. 2006;45:1403–1405
  3. Howard B, Ragsdale B, Lundquist K. Pigmented epithelioid melanocytoma: two case reports. Dermatol Online J. 2005;11:1
  4. White S, Chen S. What is “pigmented epithelioid melanocytoma?”. Am J Surg Pathol. 2005;29:1118;author reply, 1118-9
  5. Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol. 2004;28:31–40
  6. Scolyer RA, Thompson JF, Warnke K, McCarthy SW. Pigmented epithelioid melanocytoma. Am J Surg Pathol. 2004;28:1114–1115
  7. Kim JC, Murphy GF. Dysplastic melanocytic nevi and prognostically indeterminate nevomelanomatoid proliferations. Clin Lab Med. 2000;20:691–712
  8. Reed RJ. Dimensionalities: borderline and intermediate melanocytic neoplasia. Hum Pathol. 1999;30:521–524
  9. Weedon D. Borderline melanocytic tumors. J Cutan Pathol. 1985;12:266–270
  10. Brodell RT, Santa Cruz DJ. Borderline and atypical melanocytic lesions. Semin Diagn Pathol. 1985;2:63–86
  11. Su LD, Fullen DR, Sondak VK, Johnson TM, Lowe L. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Cancer. 2003;97:499
  12. Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma’ and risk assessment. Mod Pathol. 2006;19(Suppl. 2):S21–S33
  13. Llewellyn K, Barnhill RL. Distinguishing Spitz tumors from malignant melanoma: potential role of comparative genomic hybridization and fluorescence in situ hybridization in diagnosis and prognosis. Adv Anat Pathol. 2001;8:249–254
  14. Spatz A, Barnhill RL. The Spitz tumor 50 years later: revisiting a landmark contribution and unresolved controversy. J Am Acad Dermatol. 1999;40:223–228
  15. Magro CM, Crowson AN. So called ‘de novo intraepidermal epithelioid melanocytic dysplasia’ is melanoma in situ. J Cutan Pathol. 2007;34:812
  16. Millet J. De novo intraepidermal epithelioid melanocytic dysplasia. J Cutan Pathol In press.
  17. Foucar E. Debating melanocytic tumors of the skin: does an “uncertain” diagnosis signify borderline diagnostic skill?. Am J Dermatopathol. 1995;17:626–634
  18. Sachdeva M, Frambach GE, Crowson AN, Deng AC, Mihm MC, Magro CM. De novo intraepidermal epithelioid melanocytic dysplasia as a marker of the atypical mole phenotype—a clinical and pathological study of 75 patients. J Cutan Pathol. 2005;32:622–628
  19. Reed RJ. Minimal deviation melanoma. Borderline and intermediate melanocytic neoplasia. Clin Lab Med. 2000;20:745–758
  20. Robson A, Morley-Quante M, Hempel H, McKee PH, Calonje E. Deep penetrating naevus: clinicopathological study of 31 cases with further delineation of histological features allowing distinction from other pigmented benign melanocytic lesions and melanoma Histopathology. 2003;43:529–537
  21. Roesch A, Becker B, Bentink S, Spang R, Vogl A, Hagen I, et al. Ataxia telangiectasia-mutated gene is a possible biomarker for discrimination of infiltrative deep penetrating nevi and metastatic vertical growth phase melanoma. Cancer Epidemiol Biomarkers Prev. 2007;16:2486–2490
  22. Ridha H, Ahmed S, Theaker JM, Horlock N. Malignant melanoma and deep penetrating naevus—difficulties in diagnosis in children. J Plast Reconstr Aesthet Surg. 2007;60:1252–1255
  23. Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol. 2002;26:47–55
  24. Murali R, Sharma RN, Thompson JF, Stretch JR, Lee CS, McCarthy SW, et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Ann Surg Oncol. 2008;15:302–309
  25. Urso C, Borgognoni L, Saieva C, Ferrara G, Tinacci G, Begliomini B, et al. Sentinel lymph node biopsy in patients with “atypical Spitz tumors.” A report on 12 cases. Hum Pathol. 2006;37:816–823Epub 2006 May 19
  26. Kelley SW, Cockerell CJ. Sentinel lymph node biopsy as an adjunct to management of histologically difficult to diagnose melanocytic lesions: a proposal. J Am Acad Dermatol. 2000;42:527–530
  27. Roaten JB, Partrick DA, Pearlman N, Gonzalez RJ, Gonzalez R, McCarter MD. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents. J Pediatr Surg. 2005;40:232–235
  28. Gamblin TC, Edington H, Kirkwood JM, Rao UN. Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features. Ann Surg Oncol. 2006;13:1664–1670
  29. McArthur GJ, Banwell ME, Cook MG, Powell BW. The role of sentinel node biopsy in the management of melanocytic lesions of uncertain malignant potential (MUMP). J Plast Reconstr Aesthet Surg. 2007;60:952–954
  30. Urso C, Gelli R, Borgognoni L, Tinacci G, Reali UM. Positive sentinel node biopsy in a 30-month-old boy with atypical Spitz tumour (Spitzoid melanoma). Histopathology. 2006;48:884–886
  31. Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003;163:1765–1770
  32. Casorzo L, Luzzi C, Nardacchione A, Picciotto F, Pisacane A, Risio M. Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis. Melanoma Res. 2005;15:155–160
  33. Biddle DA, Evans HL, Kemp BL, El-Naggar AK, Harvell JD, White WL, et al. Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma. Am J Surg Pathol. 2003;27:673–681
  34. Lohmann CM, Iversen K, Jungbluth AA, et al. Expression of melanocyte differentiation antigens and Ki-67 in nodal nevi and comparison of Ki-67 expression with metastatic melanoma. Am J Surg Pathol. 2002;26:1351–1357

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)00773-7

doi: 10.1016/j.jaad.2009.06.042

Journal of the American Academy of Dermatology
Volume 62, Issue 3 , Pages 469-479 , March 2010

Article Tools

* Image Usage & Resolution